About BiLab

About BiLab2021-08-20T18:35:32+00:00
Overview

BiLab provides solutions for cardiopulmonary monitoring with its state-of-the-art technologies of electrical impedance tomography (EIT) and multi-channel impedance plethysmography (MIP). Noninvasive continuous monitoring of tidal volume and stroke volume is possible through fast multi-channel impedance measurements across the chest and novel data processing algorithms. BiLab supports clinical research to improve patient outcomes using these patient monitoring technologies.

History

2020

  • Series B funding from a strategic investor
  • Development of AirTom
  • Development of HemoVista
  • Clinical studies

2019

  • GMP certification from the MFDS in Korea
  • AirTom-R approval from the MFDS in Korea
  • Series A funding from a strategic investor
  • Completion of RM

2018

  • Product design and sample production
  • Animal studies and volunteer studies
  • GMP and medical device approval processes

2017

  • Seed funding from Innopolis Partners
  • Patents transfer from Kyung Hee University
  • Prototype EIT system development
  • Animal studies and clinical studies

2016

  • Founded in July 2016
  • Technology transfer from Impedance Imaging Research Center (IIRC)